author-photo

Gary Bloomgren

Biogen Idec

16

Papers

1742

Citations

Citation Trend

Filter By

Papers (10) Sort By

Journal Conference Others

Disease Prevalence, Comorbid Conditions, and Medication Utilization Among Patients with Schizophrenia in the United States

2021 Cns Spectrums
Show All
- Source
- Cite
- Save
Citations (0)
Evaluation of pregnancy outcomes from the Tysabri® (natalizumab) pregnancy exposure registry: a global, observational, follow-up study.

2016 BMC Neurology
Show All
- Source
- Cite
- Save
Citations (70)
Outcome and survival of asymptomatic PML in natalizumab‐treated MS patients

2014 Annals of clinical and translational neurology
Show All
- Source
- Cite
- Save
Citations (95)
Anti–JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathy

2014 Annals of Neurology
Show All
- Source
- Cite
- Save
Citations (341)
Evaluation of Pregnancy Outcomes from the TYSABRI® (Natalizumab) Pregnancy Exposure Registry (P02.127)

2013 Neurology
Show All
- Source
- Cite
- Save
Citations (20)
Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy

2012 Survey of Anesthesiology
Show All
- Source
- Cite
- Save
Citations (0)
Classification of Natalizumab Cases with Progressive Multifocal Leukoencephalopathy (P07.058)

2012 Neurology
Show All
- Source
- Cite
- Save
Citations (4)
Assessment of malignancy risk in patients with multiple sclerosis treated with intramuscular interferon beta-1a: retrospective evaluation using a health insurance claims database and postmarketing surveillance data

2012 Therapeutics and Clinical Risk Management
Show All
- Source
- Cite
- Save
Citations (13)
Preoperative Chemoradiotherapy for Esophageal Cancer

2012
Show All
- Source
- Cite
- Save
Citations (0)
Anti‐John Cunnigham virus antibody prevalence in multiple sclerosis patients: Baseline results of STRATIFY‐1

2011 Annals of Neurology
Show All
- Source
- Cite
- Save
Citations (125)